Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial

Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMen...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Current controlled trials in cardiovascular medicine Ročník 20; číslo 1; s. 38 - 11
Hlavní autoři:	Ballbè, Montse, Martínez, Cristina, Feliu, Ariadna, Torres, Núria, Nieva, Gemma, Pinet, Cristina, Raich, Antònia, Mondon, Sílvia, Barrio, Pablo, Hernández-Ribas, Rosa, Vicens, Jordi, Costa, Sílvia, Vilaplana, Jordi, Alaustre, Laura, Vilalta, Eva, Blanch, Roser, Subirà, Susana, Bruguera, Eugeni, Suelves, Josep Maria, Guydish, Joseph, Fernández, Esteve
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 11.01.2019 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Abstinence Biomedicine Carbon monoxide Care and treatment Case studies Clinical trial Clinical trials Estudi de casos Health Sciences Hospital patients Hospitalization Hypotheses Information management Intervention Life expectancy Medical protocols Medical research Medicine Medicine & Public Health Mental disorders Mental health Mentally ill persons Methods Motivation Pathological psychology Patient monitoring equipment Patient outcomes Protocols clínics Psicopatologia Psychiatric hospitals Public health Quality of life Quitlines Smoking Smoking cessation Statistics for Life Sciences Study Protocol Telemedicine Telephone Telèfon Tobacco habit Tobacco smoke Tractament del tabaquisme Spain Smoking cessation Clinical trial Mental disorders Telephone Quitlines
ISSN:	1745-6215, 1745-6215
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. Trial registration ClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.
Bibliografie:	ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23
ISSN:	1745-6215 1745-6215
DOI:	10.1186/s13063-018-3106-5